Skip to content

Nurix Therapeutics, Inc. NRIX Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$3.57M+228%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$2.92M+72,925%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.59M+192%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.33M+919%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$6.28M-239%
Septerna, Inc. logo
Septerna, Inc.SEPN
$294K-39.8%

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Nurix Therapeutics, Inc. (NRIX) reported increase (decrease) in prepaid expense and other assets of -$1.29M in Q4 2025.
How has Nurix Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Nurix Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 120.6% year-over-year, from $6.25M to -$1.29M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.